Scheduled service maintenance on November 22


On Friday, November 22, 2024, between 06:00 CET and 18:00 CET, GIN services will undergo planned maintenance. Extended service interruptions should be expected. We will try to keep downtimes to a minimum, but recommend that users avoid critical tasks, large data uploads, or DOI requests during this time.

We apologize for any inconvenience.

Methylphenidate promotes the interaction between motor cortex facilitation and attention processes in healthy adults performing a go/nogo task

Christoph Berger 019944f473 'datacite.yml' ändern 6 年之前
.gitignore 3d9b38dc28 Initial commit 6 年之前
BrainVisionRecorder_Marker_MPH.txt c5f4404af5 Dateien hochladen nach '' 6 年之前
LICENSE 9200cdeeeb 'LICENSE' ändern 6 年之前
README.md a4523d5583 'README.md' ändern 6 年之前
bva.zip.001 4a47931678 Dateien hochladen nach '' 6 年之前
bva.zip.002 a855c517fc Dateien hochladen nach '' 6 年之前
bva1.zip.001 ca0558260f Dateien hochladen nach '' 6 年之前
bva1.zip.002 a855c517fc Dateien hochladen nach '' 6 年之前
datacite.yml 019944f473 'datacite.yml' ändern 6 年之前
mphdata.sav ab4b39a862 Dateien hochladen nach '' 6 年之前

README.md

MPH_TMS_ERP

this repository provides additional information to the study

Methylphenidate promotes the interaction between motor cortex facilitation and attention processes in healthy adults performing a go/nogo task

Abstract The interplay between attention processes and motor cortex excitability has been rarely reported in the literature. This study investigated simultaneously the interaction between neural markers of attention and response control (both measured by event related potentials (ERP)) and motor cortical excitability. As markers of cortical excitability, short interval cortical inhibition, intracortical facilitation and long interval cortical inhibition were investigated by using transcranial magnetic stimulation under different requirement conditions (cued choice reaction test, attention/go/nogo) and their pharmacological modulation by methylphenidate (MPH). In a sample of healthy adults (n=31) MPH was administered in a dosage of 1 mg/kg body weight, maximum 60 mg, with serum level and clearance being measured. MPH modulated attentional gating and response preparation processes (increased contingent negative variation) and response inhibition (increased nogo P3). N1, cue- and go-P3 were not affected by MPH. No correlation of MPH serum level or clearance with ERP or task performance was found. Motor cortex facilitation, measured with Long-interval Cortical Facilitation (LICF), was increased under MPH in the nogo condition compared to no medication. Additionally, we found a positive correlation between LICF and the P3 amplitude under MPH, but only for the nogo condition. Taken together, MPH seems particularly to enhance response preparation processes. In our view, the correlation of MPH-induced changes in motor cortex facilitation with cognitive response inhibition monitoring can be interpreted as an increased terminal compensatory inhibition control which accompanies the MPH-induced increased motor cortex facilitation during inhibitory task demands.

files: MPH_data.sav: ERP and TMS aggregates, as well ashits, reaction times, MPH clearance, gender and age raw1.zip: raw erp and tms data BrainVisionRecorder_Marker.txt: description of experimental markers